Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Short-term Investments (2014 - 2026)

Updated

Theravance Biopharma (TBPH) posted Short-term Investments of $167.89 million for Q2 2026, up 195.2% from $56.88 million a year earlier and up 57.5% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Short-term Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, Theravance Biopharma's Short-term Investments came in at $147.55 million, up 191.9% from FY2024.

  • Annual Short-term Investments shows a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
  • In prior years, Theravance Biopharma's Short-term Investments was $50.55 million in FY2024 (-19.6%), $62.88 million in FY2023 (+114.5%), $29.31 million in FY2022 (-64.9%) and $83.51 million in FY2021 (-60.5%).
  • The Q2 2026 figure stands as the highest quarterly Short-term Investments since Q4 2020.
  • On a year-over-year basis, Short-term Investments has increased in each of the last five quarters, with growth averaging 111.1% over the last eight quarters.
  • The strongest year-over-year quarter for Short-term Investments in the past five years was Q1 2026, with growth of 426.5%; the weakest was Q4 2022, with a decline of 64.9%.
  • According to Business Quant data, Short-term Investments for the three prior quarters was $106.57 million (Q1 2026), $147.55 million (Q4 2025) and $154.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 167.89 Mn
Mar 31, 2026 106.57 Mn
Dec 31, 2025 147.55 Mn
Sep 30, 2025 154.91 Mn
Jun 30, 2025 56.88 Mn
Mar 31, 2025 20.24 Mn
Dec 31, 2024 50.55 Mn
Sep 30, 2024 67.98 Mn
Jun 30, 2024 49.73 Mn
Mar 31, 2024 46.14 Mn
Dec 31, 2023 62.88 Mn
Sep 30, 2023 62.32 Mn
Jun 30, 2023 61.86 Mn
Mar 31, 2023 53.60 Mn
Dec 31, 2022 29.31 Mn
Sep 30, 2022 68.29 Mn
Jun 30, 2022 45.56 Mn
Mar 31, 2022 53.15 Mn
Dec 31, 2021 83.51 Mn
Sep 30, 2021 94.79 Mn
API Access

Theravance Biopharma Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=TBPH&period=max&api_key=YOUR_API_KEY